ClinicalTrials.gg
Not yet recruitingNCT07750977Updated Aug 6, 2026

Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes

An interventional study of Blood Flow Restriction Training and Conventional Artistic Jump Rope Training in Neuromuscular Function and Athletic Performance Enhancement, sponsored by Shanghai University of Sport. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by Shanghai University of Sport · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The goal of this randomized controlled trial is to investigate whether blood flow restriction training can improve physical function and sports performance in artistic jump rope athletes. The study will include 30 healthy artistic jump rope athletes aged 18 to 25 years. The main questions this study aims to answer are:

  1. Does blood flow restriction training improve neuromuscular function compared with conventional training?
  2. Does blood flow restriction training improve muscle strength, power, body composition, physiological responses, and artistic jump rope performance?

Researchers will compare participants receiving blood flow restriction training with participants performing conventional training to determine whether blood flow restriction training provides additional benefits. Participants will complete an 8-week training program and undergo assessments before and after the intervention, including muscle function tests, physical performance tests, body composition measurements, and physiological response evaluations.

Read the detailed description

Blood flow restriction (BFR) training is an exercise method that uses external pressure to partially restrict blood flow during exercise. This method may allow individuals to achieve improvements in muscle function and physical performance while using lower exercise loads. However, the effects of BFR training in artistic jump rope athletes are not fully understood.

The purpose of this study is to examine the effects of an 8-week blood flow restriction training program on neuromuscular function, body composition, physiological responses, and sport-specific performance in artistic jump rope athletes.

Approximately 30 healthy artistic jump rope athletes aged 18 to 25 years will participate in this study. Participants will be randomly assigned to either a blood flow restriction training group or a conventional training group. Both groups will continue their regular artistic jump rope training during the intervention period. The blood flow restriction training group will complete selected training sessions with individualized blood flow restriction pressure.

Before and after the 8-week intervention, researchers will assess changes in neuromuscular function, upper and lower limb muscle strength, explosive power, jump rope-specific performance, body composition, heart rate responses, and blood lactate responses.

This study may provide information about whether blood flow restriction training can be used as an effective training strategy to improve physical function and performance characteristics in artistic jump rope athletes.

02

Conditions studied

  • Neuromuscular Function
  • Athletic Performance Enhancement

Keywords

  • Blood Flow Restriction Training
  • Artistic Jump Rope
  • Neuromuscular Function
03

In context

Lead sponsor

Shanghai University of Sport is the lead sponsor of 21 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  1. Adults aged 18 to 25 years.
  2. Current artistic jump rope athletes with at least 2 years of regular artistic jump rope training experience.
  3. Participants who are able to perform artistic jump rope skills and complete all study-related assessments and training procedures.
  4. Participants who are physically healthy and have no medical conditions that may interfere with exercise testing or blood flow restriction training.
  5. Participants who have no acute or chronic musculoskeletal injuries affecting the upper limbs, lower limbs, or trunk.
  6. Participants who voluntarily agree to participate and provide written before enrollment.

Exclusion Criteria:

  1. Participants younger than 18 years or older than 25 years.
  2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation disorders, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise safety.
  3. Presence of acute or chronic musculoskeletal injuries, including injuries involving muscles, joints, ligaments, tendons, or bones, that prevent safe completion of study procedures.
  4. Significant pain, severe fatigue, insufficient recovery, poor sleep condition, or other health conditions that may affect exercise performance or participant safety.
  5. Use of medications, nutritional supplements, or sports supplements within the previous week that may influence cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance.
  6. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
  7. Inability to understand the study procedures or inability to complete required assessments, including physical performance tests, blood flow restriction training, or blood lactate testing.
  8. Refusal to participate in blood flow restriction training or withdrawal of informed consent during the study.

Exclusion Criteria:

  • 1. Age younger than 18 years or older than 25 years. 2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation abnormalities, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise testing or blood flow restriction training safety.

    3. Current acute or chronic injuries involving muscles, joints, ligaments, tendons, or bones that prevent safe completion of study procedures.

    4. Severe fatigue, poor recovery status, significant pain, insufficient sleep, or other conditions that may influence exercise performance or participant safety.

    5. Use of medications, nutritional supplements, or sports supplements that may affect cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance within the previous week.

    6. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.

    7. Inability or unwillingness to complete study assessments, blood flow restriction training, blood lactate testing, or other required procedures.

    8. Withdrawal of consent or inability to comply with the study protocol during the intervention period.

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Blood Flow Restriction Training Group

    Behavioral: Blood Flow Restriction Training

  • Active comparator
    Conventional Training Group

    Behavioral: Conventional Artistic Jump Rope Training

Interventions

  • BehavioralBlood Flow Restriction Training

    An 8-week blood flow restriction training program combined with regular artistic jump rope training. External pressure will be applied using a blood flow restriction device during selected training sessions.

  • BehavioralConventional Artistic Jump Rope Training

    An 8-week conventional artistic jump rope training program without blood flow restriction.

06

What researchers measure

Primary outcomes

  1. Change in Neuromuscular Function Assessed by Surface Electromyography and Maximal Voluntary Contraction

    Neuromuscular function will be assessed using surface electromyography (sEMG) and maximal voluntary contraction (MVC) testing. Outcome measures include muscle activation amplitude, root mean square (RMS, μV), integrated electromyography (iEMG, μV·s), mean power frequency (MPF, Hz), and maximal voluntary contraction force (N).

    Time frame: Baseline and after 8 weeks of intervention

Secondary outcomes

  1. Change in Upper Limb Muscle Strength Assessed by Hand Grip Strength Test

    Upper limb muscle strength will be assessed using grip strength testing. The outcome measure is maximal voluntary grip force (kg) measured during maximal effort contraction.

    Time frame: Baseline and after 8 weeks of intervention

  2. Change in One-Repetition Maximum Strength

    Maximal muscle strength will be assessed using one-repetition maximum (1RM) testing. The outcome measure is the maximal load successfully completed during the strength test (kg).

    Time frame: Baseline and after 8 weeks of intervention

  3. Change in Lower Limb Explosive Power Assessed by Three-Dimensional Force Platform

    Lower limb explosive power and jump performance will be assessed using a three-dimensional force platform during jump testing. Outcome measures include jump height (cm), peak ground reaction force (N), peak power output (W), and rate of force development (N/s).

    Time frame: Baseline and after 8 weeks of intervention

  4. Change in Upper Limb Anaerobic Power During Wingate Test

    Upper limb anaerobic power will be assessed using a 30-second upper limb Wingate test performed on an arm crank ergometer. Outcome measures include peak power output (W), mean power output (W), relative peak power output (W/kg), total work (J), and fatigue index (%).

    Time frame: Baseline and after 8 weeks of intervention

  5. Change in Lower Limb Anaerobic Power During Wingate Test

    Lower limb anaerobic power will be assessed using Wingate cycling tests. Outcome measures include peak power output (W), mean power output (W), relative peak power output (W/kg), total work (J), and fatigue index (%). A 6-second Wingate test will assess explosive power, and a 30-second Wingate test will assess anaerobic capacity and fatigue-related performance.

    Time frame: Baseline and after 8 weeks of intervention

  6. Change in Body Composition Assessed by Dual-Energy X-ray Absorptiometry

    Body composition will be assessed using dual-energy X-ray absorptiometry (DXA). Outcome measures include body mass (kg), body fat percentage (%), fat mass (kg), lean body mass (kg), and bone mineral content (kg).

    Time frame: Baseline and after 8 weeks of intervention

  7. Change in Physiological Responses During Exercise

    Physiological responses will be assessed using heart rate monitoring and blood lactate testing. Outcome measures include resting heart rate (beats/min), peak heart rate (beats/min), heart rate recovery (beats/min), and blood lactate concentration (mmol/L).

    Time frame: Baseline and 8 weeks after intervention

  8. Change in Dynamic Balance Performance

    Dynamic balance performance will be assessed using the Y Balance Test. Outcome measures include anterior reach distance (cm), posteromedial reach distance (cm), posterolateral reach distance (cm), and composite reach score (%).

    Time frame: Baseline and 8 weeks after intervention

  9. Change in Short-Duration Rope Turning Performance

    Short-duration rope turning performance will be assessed using a 10-second maximal rope turning test. Outcome measures include total repetitions completed within 10 seconds and average movement frequency (repetitions/s).

    Time frame: Baseline and after 8 weeks of intervention

07

Study locations

1 site
  • Shanghai University of Sport, School of Physical EducationKun
    Shanghai, Shanghai Municipality 200000, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Dec 2026, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 25, 2026
First posted
Aug 6, 2026
StartEst.
Aug 30, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Dec 15, 2026
Last update
Aug 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07750977
Lead sponsor
Shanghai University of Sport
Responsible party
Zhu kun (Professor, Shanghai University of Sport) — Principal investigator
First posted
Aug 6, 2026
Start date
Aug 30, 2026 (estimated)
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Aug 6, 2026

Study contacts

Shijun Jin, student
Contact
15670976576@163.com
86+15670976576
Liubin Fu, Student
Contact
1076102965@qq.cn
86+15329763941
kun Zhu, Professor
principal investigator · Shanghai University of Sport
Jing Wang, Student
study director · Shanghai University of Sport

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion